These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients. Su LD, Fullen DR, Sondak VK, Johnson TM, Lowe L. Cancer; 2003 Jan 15; 97(2):499-507. PubMed ID: 12518375 [Abstract] [Full Text] [Related]
3. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Ludgate MW, Fullen DR, Lee J, Lowe L, Bradford C, Geiger J, Schwartz J, Johnson TM. Cancer; 2009 Feb 01; 115(3):631-41. PubMed ID: 19123453 [Abstract] [Full Text] [Related]
18. The prognostic importance of sentinel lymph node biopsy in thin melanoma. Ranieri JM, Wagner JD, Wenck S, Johnson CS, Coleman JJ. Ann Surg Oncol; 2006 Jul 01; 13(7):927-32. PubMed ID: 16788753 [Abstract] [Full Text] [Related]
19. Utility of lymph node assessment for atypical spitzoid melanocytic neoplasms. Ghazi B, Carlson GW, Murray DR, Gow KW, Page A, Durham M, Kooby DA, Parker D, Rapkin L, Lawson DH, Delman KA. Ann Surg Oncol; 2010 Sep 01; 17(9):2471-5. PubMed ID: 20224858 [Abstract] [Full Text] [Related]
20. Our experience of melanoma thickness as a predictor of outcome of sentinel node biopsy. Homolak D, Vucetić B, Puljiz Z, Blajć I, Vurnek Zivković M, Situm M. Coll Antropol; 2008 Oct 01; 32 Suppl 2():57-60. PubMed ID: 19138008 [Abstract] [Full Text] [Related] Page: [Next] [New Search]